Takaaki Tokito

Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer

Scott Antonia, Augusto Villegas, Davey B. Daniel et al. · New England Journal of Medicine · 2017 · 4.4K citations · Full text

Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC

Scott Antonia, Augusto Villegas, Davey B. Daniel et al. · New England Journal of Medicine · 2018 · 2.7K citations · Full text

Predictive relevance of PD-L1 expression combined with CD8+ TIL density in stage III non-small cell lung cancer patients receiving concurrent chemoradiotherapy

Takaaki Tokito, Koichi Azuma, Akihiko Kawahara et al. · European Journal of Cancer · 2016 · 185 citations

Concurrent Chemoradiotherapy, Cancer Immunosurveillance, Pd-l1 Expression +10

Prognostic impact of cancer cachexia in patients with advanced non-small cell lung cancer

Madoka Kimura, Tateaki Naito, Hirotsugu Kenmotsu et al. · Supportive Care in Cancer · 2014 · 177 citations

Prognostic Impact, Cancer Cachexia, Medicine +9

Significance of Programmed Cell Death-Ligand 1 Expression and its Association with Survival in Patients with Small Cell Lung Cancer

Hidenobu Ishii, Koichi Azuma, Akihiko Kawahara et al. · Journal of Thoracic Oncology · 2014 · 175 citations

Medicine, Immunology, Cell Death +7